The Egyptian Exchange Listing Committee has announced listing of the Macro Group Pharmaceuticals Company (Macro Capital) in the main stock market.
The issued capital of Macro Capital amounted to EGP 115.4m distributed over 577.3 million shares, with a nominal value of EGP 0.20 per share. The shares will be listed on the EGX as of 13 January 2022.
The company intends to offer 45% of its total shares in both IPO and private placement within a month after the registration with the Financial Regulatory Authority (FRA), which took place on 23 December 2021.
The registration shall be considered as if it did not exist in the event that the company did not offer its shares within a month from the date of its registration with the Authority and that items (1, 2, 3) of Article (7) of the listing rules are fulfilled unless this period is extended with the approval of the Authority.
Meanwhile, the EGX Listing Committee also approved switching the Marseilia Egyptian Gulf Real Estate Investment Company from the small and medium-sized enterprises (SMEs) market to the main market.
